• Create account
  • Log in
Clinical Guidelines
  • Home
  • About
    • About the clinical guidelines
    • Declaring and dealing with competing interests
    • Frequently asked questions
    • Guideline journal articles
  • CCA guidelines
    • Barrett's Oesophagus
    • Bowel cancer
      • Colorectal cancer
      • Surveillance colonoscopy
    • Endometrial cancer
    • Cervical cancer screening
    • Lung cancer
      • Lung cancer prevention & diagnosis
      • Lung cancer treatment
    • Prostate cancer
      • Advanced prostate cancer
      • PSA testing
    • Sarcoma
    • Skin cancer
      • Melanoma
      • Keratinocyte cancer (non-melanoma)
    • Pain management
    • Archive of CCA guidelines
  • COSA guidelines
    • Adolescents and Young Adult (AYA) guidelines
      • AYA cancer fertility preservation
      • AYA early cancer detection
      • AYA psychosocial management
    • Cancer therapy medication safety
    • Gastroenteropancreatic neuroendocrine tumours
    • Head & neck cancer nutrition
    • Teleoncology
  • Hosted
    • Childhood Brain Tumour or Leukaemia
  • National Cancer Prevention Policy
  • View
  • View form
  • Code
  • History
  • Refresh
  • What links here
  • Related changes
  • Special pages
  • Permanent link
  • Page information
  • Browse properties

Citation:Scottish Intercollegiate Guidelines Network (SIGN) 2014

From Cancer Guidelines Wiki
Jump to:navigation, search

Citation


Scottish Intercollegiate Guidelines Network (SIGN). Sign 137: Management of lung cancer. A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network; 2014 Available from: http://www.sign.ac.uk/guidelines/fulltext/137/index.html.



Critical appraisals

  • Assign a critical appraisal


Compare quality appraisals for each clinical question

Cited by

  1. For patients undergoing workup for known or suspected lung cancer, what is the optimal timing of PET/CT? Before or after tissue biopsy confirmation?
  2. In patients considered for curative treatment of non-small cell lung cancer, is MRI more effective than CT scan for the diagnosis of brain metastases?
  3. What is the optimal model (provider) of care for the follow up of people with lung cancer who have had curative intent treatment?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Scottish_Intercollegiate_Guidelines_Network_(SIGN)_2014&oldid=90142"
Cancer Council would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.